1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. South & Central America Colorectal Cancer Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. South & Central America Colorectal Cancer Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. South & Central America Colorectal Cancer Market Regional Analysis
6.2 South & Central America Colorectal Cancer Market Revenue 2020-2028 (US$ Million)
6.3 South & Central America Colorectal Cancer Market Forecast Analysis
7. South & Central America Colorectal Cancer Market Analysis – by Modality
7.1 Diagnosis Type
- 7.1.1 Overview
- 7.1.2 Diagnosis Type: South & Central America Colorectal Cancer Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.2 Therapy Type
- 7.2.1 Overview
- 7.2.2 Therapy Type: South & Central America Colorectal Cancer Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.3 Imaging Type
- 7.3.1 Overview
- 7.3.2 Imaging Type: South & Central America Colorectal Cancer Market – Revenue and Forecast, 2020-2028 (US$ Million)
8. South & Central America Colorectal Cancer Market Analysis – by End User
8.1 Hospitals and Diagnostic & Research Laboratories
- 8.1.1 Overview
- 8.1.2 Hospitals and Diagnostic & Research Laboratories : South & Central America Colorectal Cancer Market – Revenue and Forecast, 2020-2028 (US$ Million)
9. South & Central America Colorectal Cancer Market – South and Central America Analysis
9.1 Overview
9.2 South and Central America
- 9.2.1 South & Central America Colorectal Cancer Market Breakdown, by Key
Country, 2023 and 2028 (%)
- 9.2.1.1 South & Central America Colorectal Cancer Market – Revenue and
Forecast Analysis – by Country
- 9.2.1.1 Brazil:
South & Central America Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.1.1 Brazil: South & Central America Colorectal Cancer Market Breakdown, by Modality
- 9.2.1.1.2 Brazil: South & Central America Colorectal Cancer Market Breakdown, by End User
- 9.2.1.2 Argentina:
South & Central America Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.2.1 Argentina: South & Central America Colorectal Cancer Market Breakdown, by Modality
- 9.2.1.2.2 Argentina: South & Central America Colorectal Cancer Market Breakdown, by End User
- 9.2.1.3 Rest of South and Central America :
South & Central America Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.3.1 Rest of South and Central America : South & Central America Colorectal Cancer Market Breakdown, by Modality
- 9.2.1.3.2 Rest of South and Central America : South & Central America Colorectal Cancer Market Breakdown, by End User
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments
12. Company Profiles
12.1 Abbott
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Amgen Inc.
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Bruker Corporation
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Epigenomics AG
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 F. Hoffmann-La Roche AG
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Quest Diagnostics
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 VolitionRx Limited
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations